Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0X789 | ISIN: US46333X1081 | Ticker-Symbol: I76
Tradegate
21.11.24
10:58 Uhr
3,380 Euro
+0,020
+0,60 %
1-Jahres-Chart
IRONWOOD PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
IRONWOOD PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,3603,46012:45
3,3403,46012:45

Aktuelle News zur IRONWOOD PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiIronwood Pharmaceuticals SVP verkauft Aktien für 44.884 US-Dollar1
MiIronwood Pharmaceuticals SVP verkauft Aktien im Wert von 21.868 US-Dollar2
13.11.Ironwood Pharmaceuticals, Inc.: Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference222Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Jefferies London...
► Artikel lesen
08.11.Ironwood Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary1
07.11.IRONWOOD PHARMACEUTICALS INC - 10-Q, Quarterly Report-
07.11.Ironwood Pharmaceuticals Reports Third Quarter 2024 Results111BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its third quarter 2024 results and recent business performance. "LINZESS...
► Artikel lesen
IRONWOOD PHARMACEUTICALS Aktie jetzt für 0€ handeln
07.11.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report-
06.11.Earnings Preview: Ironwood Pharmaceuticals5
30.09.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report9
30.09.Ironwood Pharmaceuticals' SWOT analysis: apraglutide potential boosts stock outlook16
09.09.Leerink sets Ironwood Pharma at Market Perform rating with consistent target12
02.09.Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?11
14.08.Ironwood Pharmaceuticals executive sells over $42k in stock7
09.08.Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates6
08.08.IRONWOOD PHARMACEUTICALS INC - 10-Q, Quarterly Report4
08.08.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report6
08.08.Ironwood Pharmaceuticals Reports Second Quarter 2024 Results210BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. "We...
► Artikel lesen
20.06.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report4
09.05.Ironwood Pharmaceuticals Reports First Quarter 2024 Results235BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its first quarter 2024 results and recent business performance. "In the...
► Artikel lesen
15.02.Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance381BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its fourth quarter and full year 2023 results and recent business performance. "In...
► Artikel lesen
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1